Introduction
Carbenicillin (BRL 2064, Pyopent)-disodium a-carboxybenzyl penicillin-is a new semi-synthetic penicillin having a wide spectrum of antibacterial activity. It is not absorbed following oral administration and must therefore be given by injection (Acred et al., 1967) . Animal studies have shown carbenicillin to be virtually non-toxic. .
Carbenicillin is active against Gram-negative organisms including Escherichia coli, and Proteus strains. Its Strains of Pseudomonas aeruginosa are sensitive to 12*5-250 ,ug/ml of carbenicillin, the majority being sensitive to 50 ,ug/ml . Although this degree of activity is considerably less than that generally accepted for a useful systemically administered antibiotic the high urinary concentrations of carbenicillin obtainable following intramuscular dosage have enabled Pseudomonas aeruginosa infections of the urinary tract to be treated successfully (Brumfitt, Percival & Leigh, 1967) . The successful treatment of severe systemic infections such as septicaemia and meningitis, however, depends on the attainment and maintenance of blood levels at least as high as the minimum inhibitory concentration. In the case of Pseudomonas aeruginosa strains, therefore, blood levels in the region of 100,ug/ml are required.
Transient levels of this order may be achieved following 1-g intravenous doses of carbenicillin , but the maintenance of such a level requires either repeated intravenous injections or continuous infusion. The low toxicity of carbenicillin enables large doses to be given with safety and if probenecid is given by mouth in addition-sustained blood levels sufficiently high to inhibit strains of Pseudomonas aeruginosa and other Gram-negative organisms may be achieved (Robinson & Sutherland, 1967 There was an immediate improvement following this therapy with fall in pyrexia, sterilization of CSF and fall in white cell count. On discontinuation of treatment the patient continued to improve although she was left with a residual neurological defect. Case 4
A 19-year-old girl admitted to St George's Hospital Neurosurgical Unit with symptoms of an intracranial space-occupying lesion was found on investigation to have a retrosellar solid tumour. Following craniotomy and ventricular drainage a deterioration in the patient's condition was apparent and a paracolon organism was isolated from the CSF. There was no response to treatment with high intravenous dosage of ampicillin together with intrathecal ampicillin and steroids, cultures from the CSF remaining positive. Bacteriological sensitivity tests showed that the organism was considerably more sensitive to carbenicillin than to ampicillin. Carbenicillin was therefore given in a dose of 24 g daily 
Results and discussion
The onset of Pseudomonas aeruginosa septicaemia is almost invariably a fatal complication of any illness since by the time the organism is identified an overwhelming infection is present. In order that treatment may stand a chance of being effective antibiotic therapy must be instituted on a presumptive diagnosis. Frei et al. (1965) showed that the median survival time from the first positive blood-culture was only 2 days and that only two patients out of twenty-three lived more than 7 days after the first positive blood culture had been obtained.
Case 1 in this study in fact survived 9 days after his first positive blood-culture and his temporary clinical improvement could only be attributed to carbenicillin before he developed terminal Esch. coli and Klebsiella pneumoniae septicaemia.
Case 2 almost certainly had Ps. aeruginosa septicaemia and had progressively deteriorated in spite of hydrocortisone and colistin therapy. The administration of an intravenous carbenicillin infusion resulted in a gradual improvement in his condition and he was able to be discharged in remission following a short course of chloramphenicol for a clinical bronchopneumonia infection.
In both Cases 1 and 2 blood-levels considerably higher than those required to inhibit the strain of Pseudomonas aeruginosa (25 ,ug/ml) were consistently obtained. It is interesting that both these patients, however, continued to harbour the organism on the skin, throat or nose during treatment and that Case 2 subsequently developed a Pseudomonas infection of the urinary tract. There was, however, no suggestion of any decreased sensitivity to carbenicillin of the later isolates. Although no Pseudomonas aeruginosa could be isolated from blood culture during treatment from Case 1, superinfection occurred with K. pneumoniae which is invariably resistant to carbenicillin. The sensitivity of the Esch. coli strain isolated was not determined.
In both meningitis patients (Cases 3 and 4) there was, following carbenicillin treatment, a rapid return towards normality in the CSF findings, the results of which are shown in Fig. 1  and 2 . The Ps. aeruginosa strain isolated from Case 3 was fairly resistant to carbenicillin having an MIC of 125 ,ug/ml but serum levels in excess of this figure were frequently obtained. Since the 24-hr CSF levels in this patient varied from 14 to 46,ug/ml levels prior to this must have been considerably higher. This patient's CSF culture became sterile after the first intrathecal and subdural administration of carbenicillin and remained so. Her CSF cell count dropped from 1000 to 10/mm3 after 6 days and her clinical state improved. Case 4 (Fig. 2) in spite of ampicillin therapy showed consistently positive CSF cultures, the paracolon organism having an MIC of 50,ug/ml to ampicillin. In view of the greater sensitivity of the organism to carbenicillin (25,g/ml) her treatment was changed to this penicillin and the CSF became sterile within 4 days; improvement of cell counts became normal within 2 weeks. Serum carbenicillin levels in this patient were consistently higher than the level required to inhibit the infecting organism and the particularly high levels obtained in the cerebrospinal fluid occasioned no signs of cerebral irritation.
Regular blood counts and liver function tests revealed no evidence of any toxic effect due to carbenicillin. 
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